ea0073oc6.2 | Oral Communications 6: Calcium and Bone | ECE2021
Zhukouskaya Volha
, Jauze Louisa
, Charles Séverine
, Leborgne Christian
, Hilliquin Stéphane
, Sadoine Jérémy
, Slimani Lotfi
, Baroukh Brigitte
, van Wittenberghe Laetitia
, Daniele Natalie
, Rajas Fabienne
, Linglart Agnès
, Mingozzi Federico
, Chaussain Catherine
, Bardet Claire
, Ronzitti Giuseppe
Adeno‐associated virus (AAV) gene therapy reached the maturity and a liver-targeting approach is currently used as a replacement treatment for rare hepatic and muscular diseases. X-linked hypophosphatemia (XLH) is a rare disease associated with hyperfunction of fibroblast growth factor 23 (FGF23) in bone and characterized by severe skeletal deformities and short stature. The current medical therapies for XLH requires life-long repeated treatment presenting major limitati...